|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.12 NOK | -5.78% |
|
+4.95% | -70.56% |
| Apr. 25 | Circio Holding ASA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Apr. 17 | Circio Establishes In Vivo Proof-of-Concept for Circular RNA Platform | MT |
Targovax ASA reported earnings results for the fourth quarter ended December 31, 2022. For the fourth quarter, the company reported revenue was NOK 10 million. Net loss was NOK 22.2 million compared to NOK 26.64 million a year ago.
Basic loss per share from continuing operations was NOK 0.12 compared to NOK 0.28 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -70.56% | 1.75M | |
| +9.44% | 115B | |
| +12.76% | 107B | |
| -13.65% | 22.31B | |
| -3.44% | 21.6B | |
| -5.26% | 18.23B | |
| -38.57% | 17.62B | |
| +7.46% | 14.26B | |
| +34.95% | 12.37B | |
| -26.71% | 8.28B |
CIRCIO HOLDING ASA 